Roundview Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $984K | Hold |
58,709
| – | – | 0.07% | 215 |
|
|
2025
Q1 | $902K | Hold |
58,709
| – | – | 0.07% | 209 |
|
|
2024
Q4 | $1.29M | Buy |
58,709
+1,850
| +3% | +$40.8K | 0.09% | 188 |
|
|
2024
Q3 | $1.02M | Buy |
56,859
+6,000
| +12% | +$108K | 0.07% | 216 |
|
|
2024
Q2 | $826K | Hold |
50,859
| – | – | 0.07% | 222 |
|
|
2024
Q1 | $718K | Buy |
50,859
+24,300
| +91% | +$343K | 0.06% | 232 |
|
|
2023
Q4 | $277K | Buy |
+26,559
| New | +$277K | 0.03% | 284 |
|